| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
78,087 |
71,022 |
$4.14M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
628 |
423 |
$1.90M |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
7,040 |
1,727 |
$1.37M |
| 99233 |
Prolong inpt eval add15 m |
16,372 |
6,622 |
$1.07M |
| 52000 |
|
7,393 |
7,075 |
$985K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,848 |
10,576 |
$941K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
11,554 |
6,253 |
$909K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,530 |
21,250 |
$852K |
| 99215 |
Prolong outpt/office vis |
10,918 |
9,082 |
$818K |
| 77014 |
|
9,808 |
2,603 |
$610K |
| 99205 |
Prolong outpt/office vis |
4,036 |
3,933 |
$450K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,990 |
1,336 |
$280K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
1,825 |
1,804 |
$257K |
| 99223 |
Prolong inpt eval add15 m |
2,028 |
1,966 |
$225K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,483 |
3,018 |
$214K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
4,268 |
2,468 |
$193K |
| 51798 |
|
26,040 |
24,157 |
$191K |
| 96367 |
|
7,769 |
4,323 |
$175K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,604 |
8,717 |
$127K |
| 81002 |
|
59,115 |
53,294 |
$127K |
| 31231 |
|
796 |
751 |
$113K |
| 36415 |
Collection of venous blood by venipuncture |
37,296 |
28,063 |
$84K |
| 77427 |
|
796 |
430 |
$83K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,864 |
11,415 |
$68K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
116 |
73 |
$66K |
| 77336 |
|
1,376 |
833 |
$62K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,694 |
2,576 |
$55K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
292 |
267 |
$42K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
287 |
253 |
$38K |
| 51729 |
|
136 |
132 |
$37K |
| 99243 |
|
449 |
437 |
$37K |
| 76775 |
|
1,476 |
1,301 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
532 |
511 |
$32K |
| 30140 |
|
249 |
213 |
$30K |
| 92557 |
|
1,006 |
971 |
$27K |
| 99222 |
Initial hospital care, per day, moderate complexity |
342 |
338 |
$27K |
| 51741 |
|
5,257 |
4,251 |
$26K |
| 51797 |
|
274 |
246 |
$26K |
| 51728 |
|
147 |
121 |
$24K |
| 87799 |
|
278 |
258 |
$20K |
| 31237 |
|
70 |
53 |
$20K |
| 31579 |
|
140 |
132 |
$17K |
| 99254 |
|
131 |
123 |
$15K |
| 51792 |
|
64 |
64 |
$15K |
| J0897 |
Injection, denosumab, 1 mg |
12 |
12 |
$15K |
| 92567 |
|
1,337 |
1,278 |
$14K |
| 96417 |
|
240 |
133 |
$13K |
| 87492 |
|
288 |
266 |
$12K |
| 87652 |
|
310 |
287 |
$11K |
| 87512 |
|
298 |
278 |
$11K |
| 87592 |
|
289 |
266 |
$10K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
9,992 |
4,561 |
$9K |
| 87500 |
|
286 |
276 |
$9K |
| 87641 |
|
277 |
255 |
$8K |
| 96411 |
|
175 |
107 |
$8K |
| 87653 |
|
282 |
259 |
$8K |
| 76857 |
|
555 |
492 |
$8K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
23 |
13 |
$7K |
| J1750 |
Injection, iron dextran, 50 mg |
62 |
41 |
$7K |
| 87481 |
|
265 |
242 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
283 |
233 |
$7K |
| 87640 |
|
248 |
227 |
$7K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
31 |
28 |
$6K |
| 52332 |
|
76 |
68 |
$6K |
| 51784 |
|
295 |
239 |
$6K |
| 74420 |
|
373 |
351 |
$6K |
| 50590 |
|
14 |
13 |
$5K |
| 52224 |
|
15 |
14 |
$5K |
| 96415 |
|
219 |
138 |
$5K |
| 99459 |
|
384 |
372 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,433 |
1,879 |
$4K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
3,946 |
3,623 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
95 |
51 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
110 |
77 |
$4K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
15 |
12 |
$3K |
| 99253 |
|
34 |
34 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
125 |
67 |
$2K |
| 77334 |
|
20 |
16 |
$2K |
| 70486 |
|
31 |
26 |
$2K |
| 51701 |
|
61 |
56 |
$2K |
| 99442 |
|
101 |
100 |
$1K |
| 96409 |
|
19 |
12 |
$1K |
| 96523 |
|
65 |
51 |
$1K |
| 88313 |
|
37 |
33 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,182 |
741 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
38 |
37 |
$945.95 |
| G6002 |
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
18 |
12 |
$871.41 |
| 51700 |
|
12 |
12 |
$670.77 |
| 96368 |
|
41 |
24 |
$525.50 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
541 |
434 |
$469.08 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
16 |
12 |
$407.84 |
| J9190 |
Injection, fluorouracil, 500 mg |
36 |
12 |
$393.48 |
| 82728 |
|
39 |
37 |
$383.73 |
| 93793 |
|
59 |
38 |
$240.08 |
| 85610 |
|
115 |
66 |
$239.96 |
| 96377 |
|
17 |
12 |
$235.60 |
| 96402 |
|
13 |
13 |
$197.00 |
| J2704 |
Injection, propofol, 10 mg |
40 |
40 |
$142.79 |
| A4550 |
Surgical trays |
702 |
663 |
$50.10 |